
ADGM
Healthcare · Medical Devices · $1.8M market cap
$1.93+0.11 (+6.0%)Nov 13, 4:20 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +10.8% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 11, 2026 | Time not confirmed | -9.01 | -19.82 | -120.0% |
| Aug 11, 2026 | Before the open | -0.38 | -0.30 | +21.1% |
| May 12, 2026 | Before the open | -0.29 | -0.31 | -6.9% |
| Mar 27, 2026 | Before the open | -0.31 | -0.16 | +48.4% |
| Nov 12, 2025 | Time not confirmed | — | -0.66 | — |
| Aug 14, 2025 | Time not confirmed | — | -0.35 | — |
| May 15, 2025 | Time not confirmed | — | -0.51 | — |
| Mar 27, 2025 | Time not confirmed | — | -3.75 | — |
| Apr 6, 2023 | Time not confirmed | — | 0.05 | — |
| Nov 7, 2022 | Time not confirmed | — | 0.17 | — |
| Aug 8, 2022 | Time not confirmed | — | -0.01 | — |
| May 13, 2022 | Time not confirmed | — | -0.01 | — |
| Mar 31, 2022 | Time not confirmed | — | -0.06 | — |
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC…
| Nov 12, 2021 |
| Time not confirmed |
| — |
| -0.27 |
| — |
| Aug 12, 2021 | Time not confirmed | — | -0.01 | — |
| May 13, 2021 | Time not confirmed | — | -0.01 | — |